Steven Cohen's AVBP Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 216,660 shares of ArriVent BioPharma, Inc. (AVBP) worth $4.36 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in AVBP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 216,660 shares. Largest reduction occurred in Q2 2024, reducing 28,900 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ArriVent BioPharma (AVBP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ArriVent BioPharma (AVBP) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +216,660 | New Buy | 216,660 | $20.12 |
| Q2 2024 | -28,900 | Sold Out | 0 | $0.00 |
| Q1 2024 | +28,900 | New Buy | 28,900 | $17.86 |
Steven Cohen's ArriVent BioPharma Investment FAQs
Steven Cohen first purchased ArriVent BioPharma, Inc. (AVBP) in Q1 2024, acquiring 28,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ArriVent BioPharma, Inc. (AVBP) for 3 quarters since Q1 2024.
Steven Cohen's largest addition to ArriVent BioPharma, Inc. (AVBP) was in Q4 2025, adding 216,660 shares worth $4.36 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 216,660 shares of ArriVent BioPharma, Inc. (AVBP), valued at approximately $4.36 M.
As of the Q4 2025 filing, ArriVent BioPharma, Inc. (AVBP) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ArriVent BioPharma, Inc. (AVBP) was 216,660 shares, as reported at the end of Q4 2025.